Protagonist Therapeutics
PTGX
PTGX
41 hedge funds and large institutions have $144M invested in Protagonist Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 43 → 41 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
41
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$884K | |
| 2 | +$689K | |
| 3 | +$538K | |
| 4 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
+$295K |
| 5 |
First Manhattan
New York
|
+$293K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$928K | |
| 3 | -$405K | |
| 4 |
GAMA
Graticule Asia Macro Advisors
New York
|
-$328K |
| 5 |
Renaissance Technologies
New York
|
-$294K |